GEN Exclusives

More »

GEN News Highlights

More »
Feb 4, 2008

Karo Bio and Zydus Cadila Enter Inflammatory Disease Partnership

  • Karo Bio and Zydus Cadila are working together to discover and develop selective glucocorticoid receptor modulators for the treatment of inflammatory diseases.

    Under the three-year research collaboration Karo Bio will utilize its expertise in nuclear receptor drug discovery including structural biology, drug design, and compound characterization. Zydus Cadila will initiate a focused drug discovery and development program, undertaking preclinical studies, IND application filing, and clinical trials.

    Both parties will equally share the costs and and rewards from this partnership.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?